Description
Medical Ceramics Market Forecast till 2027
Market Overview
Global Medical Ceramics Market is anticipated to exhibit a CAGR of 5.98% during the review period of 2020 to 2027. The growth of the global medical ceramics market is propelled by the increasing demand for medical ceramics in medical devices, technological expansions in medical ceramics, and favorable government initiatives for medical ceramics in recent years.
The Global Medical Ceramics market is expected to witness healthy market growth during the review period owing to the largest market value of USD 19,942.58 Million in 2019. The global medical ceramics market is attributed to the increasing awareness about oral hygiene and aesthetics, leading to a high acceptance of all-ceramic implants, growing awareness regarding various orthopedic and dental applications such as hip and tooth replacements, rising private investment in medical ceramics, and increasing use of medical ceramics in various applications. However, some harmful effects posed by medical ceramics and unmet medical needs are expected to hinder the market growth during the review period.
Market Segmentation
Global Medical Ceramics Market has been categorized into Type, Application, and End User.
The market, in terms of type, has been classified into bioinert ceramics, bioactive ceramics, bioresorbable ceramics, and piezoceramics. The bioinert ceramics segment is further divided into zirconia, alumina, and others. The bioactive ceramics segment is further bifurcated into hydroxyapatite and glass-ceramics.
Based on application, the market has been classified into dental applications, orthopedic applications, cardiovascular, medical devices, plastic surgery, and others. The dental applications segment is further classified into dental implants, dental crowns & bridges, braces, inlays & Onlays, and dental bone grafts & substitutes. The orthopedic applications segment is further divided into joint replacement, fracture fixation, and orthobiologics. Based on end-user, the market is segmented into hospitals & clinics, specialty centers, and others.
Regional Analysis
Geographically the global medical ceramics market has been segmented into the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas is anticipated to account for the largest market share owing to the raised prevalence of dental decay, rising injuries, and the fastest adoption of medical ceramics in the medical devices market. The regional market growth is attributed to the high demand for dental services and adequate availability of dental professionals in the region.
Europe held the second-largest share in the global medical ceramics market owing to the rising number of patients for hip and knee replacements, the availability of products in the region, and the existence of a huge geriatric population.
Asia-Pacific is expected to be the third-largest market owing to the rising number of adults residing in the region suffering from dental avulsion, tooth decay, and gum disease, resulting in loss of teeth.
The medical ceramics market in Middle East & Africa is expected to register steady growth because of the rising emergence of major players in the region offering medical ceramics.
Major Players
The key players in the global medical ceramics market include Zimmer Biomet Holdings, Inc. (US), Institut Straumann AG (Switzerland), 3M (US), DePuy Synthes (US), Stryker (US), CoorsTek, Inc. (US), CeramTec (Germany), Nobel Biocare (Switzerland), Kyocera Corporation (Japan), and Rauschert Group (Germany).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Table of Contents
TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION 17
2.2 SCOPE OF THE STUDY 17
2.3 RESEARCH OBJECTIVE 17
2.4 MARKET STRUCTURE 17
2.5 ASSUMPTIONS & LIMITATIONS 18
3 RESEARCH METHODOLOGY
3.1 DATA MINING 19
3.2 SECONDARY RESEARCH 20
3.3 PRIMARY RESEARCH 21
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 22
3.5 FORECASTING TECHNIQUES 22
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 24
3.6.1 BOTTOM-UP APPROACH 25
3.6.2 TOP-DOWN APPROACH 25
3.7 DATA TRIANGULATION 26
3.8 VALIDATION 26
4 MARKET DYNAMICS
4.1 OVERVIEW 27
4.2 DRIVERS 28
4.2.1 INCREASING NUMBER OF MEDICAL PROCEDURES USING MEDICAL CERAMICS 28
4.2.2 GROWING GERIATRIC POPULATION PRONE TO CHRONIC ILLNESS 28
4.2.3 RAPID INFLUX OF NOVEL PRODUCT VARIETIES AND TECHNOLOGICAL ADVANCEMENTS IN MEDICAL CERAMICS 29
4.2.4 FAVORABLE GOVERNMENT INITIATIVES AND RISING NUMBER OF CLINICAL TRIALS 29
4.3 RESTRAINT 31
4.3.1 POTENTIALLY HARMFUL EFFECTS OF MEDICAL CERAMICS 31
4.4 OPPORTUNITY 31
4.4.1 COLLABORATIONS WITH SMALL MARKET PLAYERS 31
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 32
5.1.1 R&D AND DESIGNING 33
5.1.2 MANUFACTURING 33
5.1.3 DISTRIBUTION & SALES 33
5.1.4 POST-SALES MONITORING 33
5.2 PORTER’S FIVE FORCES MODEL 34
5.2.1 THREAT OF NEW ENTRANTS 34
5.2.2 BARGAINING POWER OF SUPPLIERS 35
5.2.3 THREAT OF SUBSTITUTES 35
5.2.4 BARGAINING POWER OF BUYERS 35
5.2.5 INTENSITY OF RIVALRY 35
5.3 COVID-19 IMPACT ANALYSIS 36
5.3.1 IMPACT ON R&D 36
5.3.2 IMPACT ON SUPPLY CHAIN 36
5.3.3 IMPACT ON MANUFACTURERS 37
6 GLOBAL MEDICAL CERAMICS MARKET, BY TYPE
6.1 OVERVIEW 38
6.2 BIOINERT CERAMICS 39
6.3 BIOACTIVE CERAMICS 40
6.4 BIORESORBABLE CERAMICS 41
6.5 PIEZOCERAMICS 41
7 GLOBAL MEDICAL CERAMICS MARKET, BY APPLICATION
7.1 OVERVIEW 42
7.2 DENTAL APPLICATIONS 43
7.3 ORTHOPEDIC APPLICATIONS 44
7.4 CARDIOVASCULAR 45
7.5 MEDICAL DEVICES 45
7.6 PLASTIC SURGERY 46
8 GLOBAL MEDICAL CERAMICS MARKET, BY END USER
8.1 OVERVIEW 47
8.2 HOSPITALS & CLINICS 48
8.3 SPECIALTY CENTERS 48
9 GLOBAL MEDICAL CERAMICS MARKET, BY REGION
9.1 OVERVIEW 49
9.2 AMERICAS 50
9.2.1 NORTH AMERICA 53
9.2.1.1 US 56
9.2.1.2 CANADA 59
9.2.2 LATIN AMERICA 61
9.3 EUROPE 64
9.3.1 WESTERN EUROPE 67
9.3.1.1 GERMANY 70
9.3.1.2 FRANCE 73
9.3.1.3 UK 75
9.3.1.4 ITALY 78
9.3.1.5 SPAIN 80
9.3.1.6 REST OF WESTERN EUROPE 82
9.3.2 EASTERN EUROPE 85
9.4 ASIA-PACIFIC 88
9.4.1 CHINA 91
9.4.2 JAPAN 94
9.4.3 INDIA 96
9.4.4 AUSTRALIA 99
9.4.5 SOUTH KOREA 101
9.4.6 REST OF ASIA-PACIFIC 104
9.5 MIDDLE EAST & AFRICA 107
9.5.1 MIDDLE EAST 110
9.5.2 AFRICA 113
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW 116
10.2 COMPETITIVE BENCHMARKING 117
10.3 COMPETITOR DASHBOARD 118
10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL MEDICAL CERAMICS MARKET 118
10.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MEDICAL CERAMICS MARKET 119
10.6 KEY DEVELOPMENT ANALYSIS 119
10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 120
10.7.1 PRODUCT LAUNCHES/PRODUCT APPROVALS 120
10.7.2 MERGERS/ACQUISITIONS 121
10.7.3 PARTNERSHIPS/AGREEMENTS/JOINT VENTURES 121
10.7.4 EXPANSIONS 122
11 COMPANY PROFILES
11.1 ZIMMER BIOMET HOLDINGS INC. 123
11.1.1 COMPANY OVERVIEWS 123
11.1.2 FINANCIAL OVERVIEW 124
11.1.3 PRODUCTS/SERVICES OFFERED 124
11.1.4 KEY DEVELOPMENTS 125
11.1.5 SWOT ANALYSIS 125
11.1.6 KEY STRATEGIES 126
11.2 INSTITUT STRAUMANN AG 127
11.2.1 COMPANY OVERVIEW 127
11.2.2 FINANCIAL OVERVIEW 128
11.2.3 PRODUCTS/SERVICES OFFERED 129
11.2.4 KEY DEVELOPMENTS 129
11.2.5 SWOT ANALYSIS 130
11.2.6 KEY STRATEGIES 130
11.3 3M 131
11.3.1 COMPANY OVERVIEW 131
11.3.2 FINANCIAL OVERVIEW 132
11.3.3 PRODUCTS/SERVICES OFFERED 132
11.3.4 KEY DEVELOPMENTS 133
11.3.5 SWOT ANALYSIS 133
11.3.6 KEY STRATEGIES 133
11.4 DEPUY SYNTHES 134
11.4.1 COMPANY OVERVIEW 134
11.4.2 FINANCIAL OVERVIEW 135
11.4.3 PRODUCTS/SERVICES OFFERED 135
11.4.4 KEY DEVELOPMENTS 136
11.4.5 SWOT ANALYSIS 136
11.4.6 KEY STRATEGIES 136
11.5 STRYKER 137
11.5.1 COMPANY OVERVIEW 137
11.5.2 FINANCIAL OVERVIEW 138
11.5.3 PRODUCTS/SERVICES OFFERED 138
11.5.4 KEY DEVELOPMENTS 139
11.5.5 SWOT ANALYSIS 139
11.5.6 KEY STRATEGIES 139
11.6 COORSTEK INC. 140
11.6.1 COMPANY OVERVIEW 140
11.6.2 FINANCIAL OVERVIEW 140
11.6.3 PRODUCTS/SERVICES OFFERED 140
11.6.4 KEY DEVELOPMENTS 141
11.6.5 SWOT ANALYSIS 141
11.6.6 KEY STRATEGIES 142
11.7 CERAMTEC 143
11.7.1 COMPANY OVERVIEW 143
11.7.2 FINANCIAL OVERVIEW 144
11.7.3 PRODUCTS/SERVICES OFFERED 145
11.7.4 KEY DEVELOPMENTS 145
11.7.5 SWOT ANALYSIS 146
11.7.6 KEY STRATEGIES 146
11.8 NOBEL BIOCARE HOLDING AG 147
11.8.1 COMPANY OVERVIEW 147
11.8.2 FINANCIAL OVERVIEW 148
11.8.3 PRODUCTS/SERVICES OFFERED 148
11.8.4 KEY DEVELOPMENTS 149
11.8.5 SWOT ANALYSIS 149
11.8.6 KEY STRATEGIES 149
11.9 KYOCERA CORPORATION 150
11.9.1 COMPANY OVERVIEWS 150
11.9.2 FINANCIAL OVERVIEW 150
11.9.3 PRODUCTS/SERVICES OFFERED 151
11.9.4 KEY DEVELOPMENTS 151
11.9.5 SWOT ANALYSIS 152
11.9.6 KEY STRATEGIES 152
11.10 RAUSCHERT GROUP 153
11.10.1 COMPANY OVERVIEW 153
11.10.2 FINANCIAL OVERVIEW 153
11.10.3 PRODUCTS/SERVICES OFFERED 153
11.10.4 KEY DEVELOPMENTS 153
11.10.5 SWOT ANALYSIS 154
11.10.6 KEY STRATEGIES 154
12 APPENDIX
12.1 REFERENCES 155
12.2 RELATED REPORTS 155
